Catheter Precision (VTAK) Net Income (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Catheter Precision | 2.01 Mn | 1.20 Mn | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.37% |
| Dec 31, 2025 | -237.95% |
| Sep 30, 2025 | 64.64% |
| Jun 30, 2025 | -34.37% |
| Mar 31, 2025 | -91.76% |
| Dec 31, 2024 | 39.64% |
| Sep 30, 2024 | 2.37% |
| Jun 30, 2024 | -57.76% |
| Mar 31, 2024 | -299.85% |
| Dec 31, 2023 | 65.28% |
| Sep 30, 2023 | -22.27% |
| Jun 30, 2023 | 97.63% |
| Mar 31, 2023 | -713.83% |
| Dec 31, 2022 | -71.30% |
| Sep 30, 2022 | 43.62% |
| Jun 30, 2022 | -53.74% |
| Sep 30, 2021 | 158.68% |
| Jun 30, 2021 | -1,362.12% |
| Mar 31, 2021 | -77.72% |
| Dec 31, 2020 | 23.48% |
| Sep 30, 2020 | 97.39% |
| Jun 30, 2020 | -31.42% |
| Mar 31, 2020 | 20.96% |
| Dec 31, 2019 | 44.06% |
| Sep 30, 2019 | -15.18% |
| Jun 30, 2019 | -3.05% |
| Mar 31, 2019 | 1.76% |
| Dec 31, 2018 | -210.73% |
| Sep 30, 2018 | 42.74% |
| Jun 30, 2018 | -211.73% |
| Mar 31, 2018 | 13.02% |
| Dec 31, 2017 | -80.00% |